206 related articles for article (PubMed ID: 30654161)
1. Susceptibility weighted MRI after uterine artery embolization for leiomyoma.
Yamahana Y; Katsumori T; Miura H; Asai S; Yamada S; Takahata A; Yamada K
Magn Reson Imaging; 2019 May; 58():32-37. PubMed ID: 30654161
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization.
Sutter O; Soyer P; Shotar E; Dautry R; Guerrache Y; Placé V; Opréa R; Ricbourg A; Le Dref O; Boudiaf M; Sirol M; Dohan A
Eur Radiol; 2016 Oct; 26(10):3558-70. PubMed ID: 26801165
[TBL] [Abstract][Full Text] [Related]
3. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
[TBL] [Abstract][Full Text] [Related]
4. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
[No Abstract] [Full Text] [Related]
5. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization.
Lee MS; Kim MD; Jung DC; Lee M; Won JY; Park SI; Lee DY; Lee KH
J Vasc Interv Radiol; 2013 Sep; 24(9):1361-5. PubMed ID: 23891046
[TBL] [Abstract][Full Text] [Related]
6. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization.
Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
[No Abstract] [Full Text] [Related]
7. Volume of embolic agents in uterine artery embolization for leiomyoma: relation to baseline MRI.
Katsumori T; Asai S; Yokota H; Miura H
Minim Invasive Ther Allied Technol; 2019 Jun; 28(3):186-193. PubMed ID: 30261778
[TBL] [Abstract][Full Text] [Related]
8. First Versus Second Uterine Artery Embolization for Symptomatic Leiomyoma.
Katsumori T; Miura H; Asai S
AJR Am J Roentgenol; 2017 Sep; 209(3):684-689. PubMed ID: 28639830
[TBL] [Abstract][Full Text] [Related]
9. Uterine artery embolization in single symptomatic leiomyoma: do anatomical imaging criteria predict clinical presentation and long-term outcome?
Koesters C; Powerski MJ; Froeling V; Kroencke TJ; Scheurig-Muenkler C
Acta Radiol; 2014 May; 55(4):441-9. PubMed ID: 23943627
[TBL] [Abstract][Full Text] [Related]
10. Role of uterine artery Doppler in the management of uterine leiomyoma by arterial embolization.
Naguib NN; Nour-Eldin NE; Serag-Eldin F; Mazloum YZ; Agameya AF; Abou-Seif S; Etaby AN; Lehnert T; Gruber-Rouh T; Zangos S; Ackermann H; Vogl TJ
Ultrasound Obstet Gynecol; 2012 Oct; 40(4):452-8. PubMed ID: 22173924
[TBL] [Abstract][Full Text] [Related]
11. Insufficient Leiomyoma Infarction in Uterine Artery Embolization: Relationship with Tumor Location.
Katsumori T; Yoshikawa T; Miura H
J Vasc Interv Radiol; 2019 May; 30(5):668-675.e1. PubMed ID: 30952521
[TBL] [Abstract][Full Text] [Related]
12. Timing of Uterine Artery Embolization for Leiomyoma during the Menstrual Cycle.
Katsumori T; Yoshikawa T; Sasakura Y; Yasumura T; Hisano M
J Vasc Interv Radiol; 2021 Mar; 32(3):332-338. PubMed ID: 33468366
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of imaging findings on MRI and CT after uterine artery embolization.
Verma SK; Gonsalves CF; Baltarowich OH; Mitchell DG; Lev-Toaff AS; Bergin D
Abdom Imaging; 2010 Feb; 35(1):118-28. PubMed ID: 19048334
[TBL] [Abstract][Full Text] [Related]
14. Effect of Direct Marketing for Uterine Artery Embolization on Rates of Leiomyomas, Incidental Findings, and Management After Pelvic MRI.
Gurwara S; Allen BC; Kouri B; Clingan MJ; Picard M; Leyendecker JR
J Am Coll Radiol; 2016 Jul; 13(7):775-9. PubMed ID: 27053158
[TBL] [Abstract][Full Text] [Related]
15. Leiomyoma Infarction after Uterine Artery Embolization: Influence of Embolic Agent and Leiomyoma Size and Location on Outcome.
Lacayo EA; Richman DL; Acord MR; Wolfman DJ; Caridi TM; Desale SY; Spies JB
J Vasc Interv Radiol; 2017 Jul; 28(7):1003-1010. PubMed ID: 28479027
[TBL] [Abstract][Full Text] [Related]
16. Unenhanced MR angiography of uterine and ovarian arteries after uterine artery embolization: differences between patients with incomplete and complete fibroid infarction.
Mori K; Saida T; Shibuya Y; Takahashi N; Shiigai M; Osada K; Tanaka N; Minami M
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):515-22. PubMed ID: 21584841
[TBL] [Abstract][Full Text] [Related]
17. Incidence of nonviable leiomyomas on contrast material-enhanced pelvic MR imaging in patients referred for uterine artery embolization.
Nikolaidis P; Siddiqi AJ; Carr JC; Vogelzang RL; Miller FH; Chrisman HB; Nemcek AA; Omary RA
J Vasc Interv Radiol; 2005 Nov; 16(11):1465-71. PubMed ID: 16319152
[TBL] [Abstract][Full Text] [Related]
18. Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome.
Kroencke TJ; Scheurig C; Poellinger A; Gronewold M; Hamm B
Radiology; 2010 Jun; 255(3):834-41. PubMed ID: 20392986
[TBL] [Abstract][Full Text] [Related]
19. Initial experience of uterine fibroid embolization using porous gelatin sponge particles.
Katsumori T; Kasahara T; Oda M; Kotani T
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):513-21. PubMed ID: 20574795
[TBL] [Abstract][Full Text] [Related]
20. Leiomyoma volume changes at follow-up after uterine artery embolization: correlation with the initial leiomyoma volume and location.
Naguib NN; Mbalisike E; Nour-Eldin NE; Jost A; Lehnert T; Ackermann H; Vogl TJ
J Vasc Interv Radiol; 2010 Apr; 21(4):490-5. PubMed ID: 20149688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
